Progress of 3-aminopyridinium-based synthetic receptors in anion recognition

Kumaresh Ghosh *, Avik Ranjan Sarkar , Tanmay Sarkar , Santanu Panja and Debasis Kar
Department of Chemistry, University of Kalyani, Kalyani-741235, India. E-mail: ghosh_k2003@yahoo.co.in; Fax: +91 3325828282; Tel: +91 3325828750 Ext.: 305

Received 11th February 2014 , Accepted 26th March 2014

First published on 27th March 2014


Abstract

This review describes the overall development on synthetic receptors built on the pyridinium motif with different functionalities at the 3-position in anion recognition. The review covers only the organic systems. In the designs, the pyridinium group along with the other functional motifs plays a crucial role in the binding of various anions of different shapes and sizes. Complexation characteristics are communicated through changes in 1H NMR, emission, color or gelation behaviours.


image file: c4ra01219d-p1.tif

Kumaresh Ghosh

Kumaresh Ghosh received his M.Sc. and Ph.D. in 1994 and 1999, respectively, from the Indian Institute of Technology, Kharagpur. He is currently Associate Professor of Chemistry at the University of Kalyani, India. His research thematics encompass molecular recognition and supramolecular chemistry, with a special emphasis on the design of chemosensors for neutral, cationic, and anionic substrates.

image file: c4ra01219d-p2.tif

Avik Ranjan Sarkar

Avik Ranjan Sarkar received his M.Sc. (Organic Chemistry) in 2004 from the North Bengal University, India. In 2006, he joined the Ph.D. program in the University of Kalyani, Nadia, India, under the supervision of Dr Kumaresh Ghosh. He obtained his Ph.D. in 2012. In the same year, he joined the research group of Prof. Hwan Myung Kim as a postdoctoral research fellow at Ajou University, Korea. His research interest focuses on the synthesis of two-photon probes for metal ions and organelles and its application in the biomedical field.

image file: c4ra01219d-p3.tif

Tanmay Sarkar

Tanmay Sarkar received his M.Sc. degree with specialization in organic chemistry from the University of Kalyani in 2008. He earned his Ph.D. in 2013 under the supervision of Dr Kumaresh Ghosh at the University of Kalyani. His research thesis included the design and synthesis of sensors for cations and anions. Currently, he is a postdoctoral fellow in the research group of Prof. David Margulies at the Weizmann Institute of Science, Israel.

image file: c4ra01219d-p4.tif

Santanu Panja

Santanu Panja received his M.Sc. degree with specialization in organic chemistry in 2011 from the University of Calcutta. He is now pursuing his Ph.D. at University of Kalyani under the guidance of Dr Kumaresh Ghosh. His research interest includes the design and synthesis of stimuli-responsive organogelators and sensors for cations and anions.

image file: c4ra01219d-p5.tif

Debasis Kar

Debasis Kar received his M.Sc. in Applied Chemistry in 2008 from Bengal Engineering and Science University, Shibpur, specialising in organic chemistry. He has recently submitted his Ph.D. thesis at the University of Kalyani under the supervision of Dr Kumaresh Ghosh. The main focus of his research is to develop fluorogenic and chromogenic receptors for anions and anion-responsive supramolecular gels.


Introduction

Design and synthesis of artificial receptors for anion recognition is a fertile area of research in supramolecular chemistry.1–8 Anion recognition chemistry is a rapidly developing discipline in the field of supramolecular chemistry. It began to grow during the late 1960s when Simmons and Park reported the complexation properties of series of positively charged ammonium macrocyclic hosts with halides.9 Following their report, exploration in this area began in the mid 1970s, when Lehn and coworkers described the anion-binding properties of a variety of macrobiocyclic and macrotricyclic ammonium-based receptors.10,11 After that, a tremendous growth in anion recognition chemistry occurred. Receptors for anions can be neutral and charged in nature. In anion recognition, charge receptors are considerably more attractive than neutral receptors due to their efficacy in complexation of anions involving charge–charge interaction along with other noncovalent forces.

In charged receptors, the cationic parts act as hosts for binding anions and must compete with associated counter anions. In comparison, neutral hosts for anions exhibit relatively weak binding of anions and must deal with the associated counter cations. These types are known as ion pair binding hosts. A survey of previous studies reveals that charged receptors based on guanidinium,12,13 imidazolium,14–16 benzimidazolium,17–25 polyammonium26,27 and thiourenium28–30 motifs are known and well explored in anion recognition. Similar to these charged systems, the pyridinium motif has been noted as a useful and versatile motif in devising molecular receptors for anions. This motif provides polar C–H bond as hydrogen bond donor to anions and the complex is further stabilized by charge–charge interaction. The easy incorporation of 3-aminopyridine in the desired structures with moderate to good yields and flexibility in tuning the designs are possible factors for pyridinium-based compounds to act as receptors for neutral as well as charged guest molecules. Thus, this review focuses on pyridinium-based receptors (especially 3-aminopyridinium-based) related to the sensing of different anions.

A simple pyridine amine or amide is not a good motif for anion binding. However, judicious placement of this motif with the quaternization of ring nitrogen can lead to a number of structures that are capable of binding anions with considerable efficiency. The binding of anions takes place through hydrogen bonding involving polar C–H bonds and other appended functionalities of the pyridinium motif. The hydrogen bonded complex is stabilized by charge–charge interactions. Fig. 1 highlights the various approaches in using 3-aminopyridine as the building block for various receptor structures.


image file: c4ra01219d-f1.tif
Fig. 1 Strategies to use 3-aminopyridine in building up receptor structures.

It is established that the C–H group adjacent to neutral or protonated/alkylated nitrogen atoms is often involved in hydrogen bonding in the crystal structure.31–33 Due to weakness, C–H⋯X (X = O, N, Cl, Br, I etc.) hydrogen bonds are rarely incorporated into synthetic receptors as determining forces to stabilize the complexes in solution.34 In this regard, receptors combining N-alkylpyridinium and amide groups were first prepared and employed for binding of carboxylate by Jeong et al.35 They reported that although pyridine amide 1 binds benzoate in d6-DMSO with a Ka of 16 M−1, the alkylated pyridinium motif 2 shows an increase in the Ka value (300 M−1) involving different binding modes (2 and 2a) (Table 1).35 Considering this feature Jeong et al. prepared different bispyridinium salts 3, 4 and 5 for binding of dicarboxylates. Adipate was selectively complexed with a high association constant (Ka > 5 × 105 M−1). The alkylated pyridinium groups attached to amide nitrogen exhibited increased affinities to anions and neutral guests as compared with their neutral counterparts. This result is attributed to the increase in acidities of both NH (amide) and CH (aromatic ring) proton donors induced by the quarternization of pyridine moiety. These interesting features of pyridinium moiety inspired several groups to develop pyridinium amide or urea-based receptors for anions. Of the different architectures, 3-amino or other substituted pyridines with different templates that provide various binding properties towards anions due to various binding pockets generated have been undertaken in the discussion. The introduction of fluorogenic and chromogenic moieties to the receptors enabled easy detection of anionic species, compared with the conventional 1H NMR titration methods. The recognition affinities of these receptors towards the different anions are briefly summarized in Table 1 (chemical structures can be found in the discussion).

image file: c4ra01219d-u1.tif

Table 1 Binding characteristics of different pyridinium-based hosts
Receptors Binding constant (Ka) values with some selected anions (host : guest stoichiometry, solvent and methods used)
1, 2, 3, 4, 5 (Jeong et al. ref. 35) 1 with PhCOO: Ka = 16 M−1 (1 : 1, d6-DMSO, 1H NMR)
2 with PhCOO: Ka = 300 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, d6-DMSO, 1H NMR)
3, 4 and 5 individually with adipate: Ka > 5 × 105 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, d6-DMSO, 1H NMR)
3, 4 and 5 individually with adipate: Ka > 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10% D2O/DMSO, 1H NMR)
Anions were used as NnBu4+ salts
6 and 7 (Fabbrizzi et al. ref. 36) 6 with CH3COO, F and H2PO4: log[thin space (1/6-em)]Ka > 6 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, UV-vis)
7 with CH3COO: log[thin space (1/6-em)]Ka = 5.10 ± 0.05 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, UV-vis)
7 with F: log[thin space (1/6-em)]Ka = 4.77 ± 0.02 (DMSO, UV-vis)
7 with H2PO4: log[thin space (1/6-em)]Ka = 3.11 ± 0.01 (DMSO, UV-vis)
Anions were used as NnBu4+ salts
8a–g, 9, 10, 11 and 12 (Steed et al. ref. 37a) 8a with Br: K11 = 850 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
8c with Cl: K11 > 100[thin space (1/6-em)]000 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
8c with Br: K11 = 13[thin space (1/6-em)]800 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
8c with AcO: K11 = 10[thin space (1/6-em)]500 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
8c with Cl: K11 = 15 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO, 1H NMR)
8d with Cl: K11 = 8 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO, 1H NMR)
8c with Cl: K11 = ca. 82[thin space (1/6-em)]000 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO/CD3CN 50% v/v, 1H NMR)
8d with Cl: K11 = ca. 3000 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO/CD3CN 50% v/v, 1H NMR)
9 with Cl: K11 = 17[thin space (1/6-em)]380 M−1(1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
9 with AcO: K11 = 3680 M−1(1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
10 with CH3COO: K11 = 49[thin space (1/6-em)]000 M−1(1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
11 with Br: K11 = 17 M−1(1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
12 with CH3COO: K11 = 7 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
Anions were used as NnBu4+ salts
13, 14 and 15 (Steed et al. ref. 37b) 13 with Cl: log[thin space (1/6-em)]Ka = 9.2 ± 0.3 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 4.2 ± 0.1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
13 with AcO: log[thin space (1/6-em)]Ka = 12.7 ± 0.2 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 6.0 ± 0.3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 10.5 ± 0.3 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, UV-vis)
13 with succinate: log[thin space (1/6-em)]Ka = 5.0 ± 0.2 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
13 with malonate: log[thin space (1/6-em)]Ka = 5.4 ± 0.2 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
14 with Cl: log[thin space (1/6-em)]Ka = 12.1 ± 0.4 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log Ka = 5.7 ± 0.3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
14 with AcO: log[thin space (1/6-em)]Ka = 11.6 ± 0.3 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 5.5 ± 0.2 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = < 4 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, UV-vis)
14 with succinate: log[thin space (1/6-em)]Ka = 10.5 ± 0.6(1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 5.3 ± 0.3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = < 4 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, UV-vis)
14 with malonate: log[thin space (1/6-em)]Ka = 10.0 ± 0.3 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 4.7 ± 0.3 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
15 with Cl: log[thin space (1/6-em)]Ka = 4.2 ± 0.2 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 7.7 ± 0.4 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, UV-vis)
15 with AcO: log[thin space (1/6-em)]Ka = 3.8 ± 0.2 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 5.6 ± 0.2 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = <4 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, UV-vis)
15 with succinate: log[thin space (1/6-em)]Ka = 5.5 ± 0.1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 11.2 ± 0.2(1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, UV-vis)
15 with malonate: log[thin space (1/6-em)]Ka = 5.2 ± 0.1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis); log[thin space (1/6-em)]Ka = 11.2 ± 0.2 (2[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
Anions were used as NnBu4+ salts
16 and 17 (Steed et al. ref. 38) 16 with Cl: log[thin space (1/6-em)]K11 = 2.64, log[thin space (1/6-em)]K12 = 2.18, log[thin space (1/6-em)]K13 = 1.40 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO, 1H NMR)
16 with Br: log[thin space (1/6-em)]K11 = 3.46, log[thin space (1/6-em)]K12 = 2.99, log[thin space (1/6-em)]K13 = 1.21 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO, 1H NMR)
16 with I: log[thin space (1/6-em)]K11 = 1.61, log[thin space (1/6-em)]K12 = 0.60, log[thin space (1/6-em)]K13 = 1.05 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO, 1H NMR)
16 with NO3: log[thin space (1/6-em)]K11 = 2.54, log[thin space (1/6-em)]K12 = 2.22, log[thin space (1/6-em)]K13 = 0.68 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, d6-DMSO, 1H NMR)
16 with AcO: log[thin space (1/6-em)]K11 = 3.21, log[thin space (1/6-em)]K12 = 3.70(1[thin space (1/6-em)]:[thin space (1/6-em)]1 and 1[thin space (1/6-em)]:[thin space (1/6-em)]2, d6-DMSO, 1H NMR)
16 with H2PO4: log[thin space (1/6-em)]K11 = 3.70, log[thin space (1/6-em)]K12 = 3.68(1[thin space (1/6-em)]:[thin space (1/6-em)]1 and 1[thin space (1/6-em)]:[thin space (1/6-em)]2, d6-DMSO, 1H NMR)
17 with Cl: log[thin space (1/6-em)]K11 = 3.85, log[thin space (1/6-em)]K12 = 1.96, log[thin space (1/6-em)]K13 = 2.93 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
17. Br: log[thin space (1/6-em)]K11 = 3.62, log[thin space (1/6-em)]K12 = 2.24, log[thin space (1/6-em)]K13 = 1.96 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
17. NO3: log[thin space (1/6-em)]K11 = 3.46, log[thin space (1/6-em)]K12 = 2.66, log[thin space (1/6-em)]K13 = 1.89 (1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
17. AcO: log[thin space (1/6-em)]K11 = 4.61, log[thin space (1/6-em)]K12 = 2.30, log[thin space (1/6-em)]K13 = 3.67(1[thin space (1/6-em)]:[thin space (1/6-em)]3, CD3CN, 1H NMR)
Anions were used as NnBu4+ salts
18a and 18b (Steed et al. ref. 39) 18a. Na2ATP: Ka = 70 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, D2O/CD3CN (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), 1H NMR]
19a–d and 20a–d (Steed et al. ref. 40) 19c. Br: K11 = 446 M−1, K12 = 467 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN, 1H NMR)
19c. NO3: K11 = 3090 M−1, K12 = 302 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN, 1H NMR)
20c. Br: K11 = 24[thin space (1/6-em)]550 M−1, K12 = 1990 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN, 1H NMR)
20c. NO3: K11 = 51[thin space (1/6-em)]290 M−1, K12 = 912 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN, 1H NMR)
19c. Malonate: K11 = 58[thin space (1/6-em)]800 M−1, K12 = 83 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN/d6-DMSO (60/40, v/v), 1H NMR]
19c. Malonate: K11 = 2720 M−1, K12 = 15 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, d6-DMSO, 1H NMR)
19c. Succinate: K11 = 2690 M−1, K12 = 37 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, d6-DMSO, 1H NMR)
Anions were used as NnBu4+ salts
21a–b and 22a–b (Beer et al. ref. 41) 21a. Cl: Ka = 40 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, d6-DMSO, 1H NMR)
22b. Cl: Ka = 110 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, d6-DMSO, 1H NMR)
23 and 24 (Steed et al. ref. 42) 23. Cl: log[thin space (1/6-em)]K11 = 3.95, log[thin space (1/6-em)]K12 = 3.21 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN, 1H NMR)
24. Cl: log[thin space (1/6-em)]K11 = 3.55, log[thin space (1/6-em)]K12 = 3.39 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CD3CN, 1H NMR)
Anions were used as NnBu4+ salts
25 (Ghosh et al. ref. 43) 25. F: Ka = 1.85 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
25. H2PO4: Ka = 1.03 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
25. AcO: Ka = 6.99 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
25. Propanoate: Ka = 5.07 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
25. C6H5COO: Ka = 4.12 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
Anions were used as NnBu4+ salts
26 (Ghosh et al. ref. 44) 26. H2PO4: Ka = 1.22 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. HSO4: Ka = 2.36 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. Isophthalate: Ka = 2.73 × 103 M−1(1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. Phthalate: Ka = 8.37 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. Terephthalate: Ka = 5.03 × 102 M−1(1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. Glutarate: Ka = 1.71 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. Malonate: Ka = 3.52 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
26. Succinate: Ka = 6.95 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
Anions were used as NnBu4+ salts
27 (Ghosh et al. ref. 46) 27. Oxalate: Ka = 7.94 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
27. Adipate: Ka = 5.78 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
27. Pimelate: Ka = 2.59 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
27. 1,4-Phenylenediacetate: Ka = 3.34 × 105 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
27. Terephthalate: Ka = 8.16 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
Anions were used as NnBu4+ salts
2833 (Yatsimirsky et al. ref. 47) 28. F: log[thin space (1/6-em)]Ka = 5.28 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
28. Cl: log[thin space (1/6-em)]Ka = 5.27 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
28. Br: log[thin space (1/6-em)]Ka = 5.24 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
28. I: log[thin space (1/6-em)]Ka = 3.80 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
28. H2PO4: log[thin space (1/6-em)]Ka = 4.20 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
28. AcO: log[thin space (1/6-em)]Ka = 4.40 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
28. NO3: log[thin space (1/6-em)]Ka = 4.11 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. F: log[thin space (1/6-em)]Ka = 4.36 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. Cl: log[thin space (1/6-em)]Ka = 5.65 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. Br: log[thin space (1/6-em)]Ka = 4.29 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. I: log[thin space (1/6-em)]Ka = 3.57 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. H2PO4: log[thin space (1/6-em)]Ka = 5.18 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. AcO: log[thin space (1/6-em)]Ka = 5.38 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
29. NO3: log[thin space (1/6-em)]Ka = 4.34 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
30. Cl: log[thin space (1/6-em)]Ka = 5.85 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
30. Br: log[thin space (1/6-em)]Ka = 5.40 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
30. I: log[thin space (1/6-em)]Ka = 3.80 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
30. NO3: log[thin space (1/6-em)]Ka = 4.40 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, UV-vis)
Neutral analogues 31, 32 and 33 exhibited weak binding
(Anions were used as NnBu4+ salts)
34 (Gong et al. ref. 48) 34. H2PO4: log[thin space (1/6-em)]Ka = 4.28 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/EtOH (9[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), fluorescence]
Anions were used as NnBu4+ salts
35 (Gong et al. ref. 49) 35. H2PO4: Ka = (3.0 ± 0.3) × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3, fluorescence); Ka = (5.0 ± 0.2) × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CHCl3, fluorescence)
Anions were used as NnBu4+ salts
36 (Ghosh et al. ref. 50) 36.C6H5COO: Ka = 3.46 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
36. 4-Butoxybenzoate: Ka = 8.69 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
36. Pyridine-3-carboxylate: Ka = 5.48 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
36. HSO4: Ka = 1.87 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
Anions were used as NnBu4+ salts
37(Ghosh et al. ref. 51) 37. AcO: Ka = 1.08 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
37. Propanoate: Ka = 1.25 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
37. AcO: Ka = 1.16 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
37. Propanoate: Ka = 1.04 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
37. C6H5COO: Ka = 3.02 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
37. H2PO4: Ka = 9.56 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 2% CH3CN, fluorescence)
Anions were used as NnBu4+ salts
38 and 39 (Ghosh et al. ref. 52) 38. Biotin carboxylate: Ka = 5.12 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN containing 1.2% DMSO, fluorescence)
38. Biotin methyl ester: Ka = 3.69 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN containing 1.2% DMSO, fluorescence)
38. AcO: Ka = 5.14 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN containing 1.2% DMSO, fluorescence)
38. Biotin carboxylate: Ka = 1.89 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
38. Biotin methyl ester: Ka = 6.33 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
38. AcO: Ka = 1.19 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
39. Biotin carboxylate: Ka = 4.22 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN containing 1.2% DMSO, fluorescence)
39. Biotin methyl ester: Ka = 7.05 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN containing 1.2% DMSO, fluorescence)
39. AcO: Ka = 1.91 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN containing 1.2% DMSO, fluorescence)
39. Biotin carboxylate: Ka = 9.70 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
39. Biotin methyl ester: Ka = 4.17 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
39. AcO: Ka = 1.95 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
Anions were used as NnBu4+ salts
40 (Ghosh et al. ref. 54) 40. Malonate: log[thin space (1/6-em)]Ka = 4.28 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. Succinate: log[thin space (1/6-em)]Ka = 4.93 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. Glutarate: log[thin space (1/6-em)]Ka = 5.73 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. Adipate: log[thin space (1/6-em)]Ka = 6.87 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. Pimelate: log[thin space (1/6-em)]Ka = 7.32 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. 1,4-Phenylenediacetate: log[thin space (1/6-em)]Ka = 8.93 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. Benzoate: log[thin space (1/6-em)]Ka = 5.19 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
40. Acetate: log[thin space (1/6-em)]Ka = 5.52 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
Anions were used as NnBu4+ salts
41 (Ghosh et al. ref. 55) 41. Malonate: Ka = 2.09 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
41. Succinate: Ka = 1.15 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
41. Glutarate: Ka = 4.21 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
41. Adipate: Ka = 4.68 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
41. Pimelate: Ka = 8.60 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
41. Suberate: Ka = 7.29 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
41. Terephthalate: Ka = 4.75 × 104 M (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
Anions were used as NnBu4+ salts
42 and 43 (Ghosh et al. ref. 56) 42. Malonate: log[thin space (1/6-em)]K1 = 4.44 ± 0.02, log[thin space (1/6-em)]K2 = 3.36 ± 0.03 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, DMSO, fluorescence)
42. Succinate: log[thin space (1/6-em)]K1 = 4.36 ± 0.03, log[thin space (1/6-em)]K2 = 3.36 ± 0.05 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, DMSO, fluorescence)
42. Glutarate: log[thin space (1/6-em)]K1 = 4.40 ± 0.04, log[thin space (1/6-em)]K2 = 3.63 ± 0.05 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, DMSO, fluorescence)
42. Adipate: log[thin space (1/6-em)]Ka = 4.21 ± 0.02 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
42. Pimelate: log[thin space (1/6-em)]Ka = 4.42 ± 0.04 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
42. Suberate: log[thin space (1/6-em)]Ka = 4.17 ± 0.03 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
43. Malonate: log[thin space (1/6-em)]K1 = 3.74 ± 0.02, log[thin space (1/6-em)]K2 = 4.31 ± 0.04 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, DMSO, fluorescence)
43. Succinate: log[thin space (1/6-em)]K1 = 3.69 ± 0.03, log[thin space (1/6-em)]K2 = 4.37 ± 0.05 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, DMSO, fluorescence)
43. Glutarate: log[thin space (1/6-em)]Ka = 4.14 ± 0.08 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
43. Adipate: log[thin space (1/6-em)]Ka = 4.73 ± 0.02 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
43. Pimelate: log[thin space (1/6-em)]Ka = 5.00 ± 0.01 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
43. Suberate: log[thin space (1/6-em)]Ka = 4.89 ± 0.01 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
Anions were used as NnBu4+ salts
44 (Ghosh et al. ref. 57) 44. NnBu4+ H2PO4: Ka = 9.07 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
44. Na2ATP: Ka = 3.36 × 102 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, H2O/CH3CN (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), fluorescence]
44. Na2ADP: Ka = 1.79 × 102 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, H2O/CH3CN (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), fluorescence]
45 and 46 (Ghosh et al. ref. 59) 45. Citrate: Ka = (2.34 ± 0.01) × 104 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. Pimelate: Ka = (4.05 ± 0.05) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. Adipate: Ka = (1.05 ± 0.01) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. Glutarate: Ka = (1.17 ± 0.02) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. Succinate: Ka = (1.62 ± 0.01) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. F: Ka = (1.12 ± 0.01) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. Cl: Ka = (9.94 ± 0.07) × 102 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. Br: Ka = (8.98 ± 0.07) × 102 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. I: Ka = (9.96 ± 0.07) × 102 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. H2PO4: Ka = (1.01 ± 0.03) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
45. AcO: Ka = (1.61 ± 0.02) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. Citrate: Ka = (7.02 ± 0.7) × 104 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. Pimelate: Ka = (1.62 ± 0.04) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. Adipate: Ka = (1.50 ± 0.02) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. Glutarate: Ka = (1.49 ± 0.02) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. Succinate: Ka = (1.54 ± 0.01) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. F: Ka = (1.18 ± 0.01) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. Cl: Ka = (1.07 ± 0.02) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. H2PO4: Ka = (1.81 ± 0.03) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
46. AcO: Ka = (8.21 ± 0.02) × 103 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), UV-vis]
Anions were used as NnBu4+ salts
47 (Ghosh et al. ref. 60) 47. (NnBu4+)3HP2O7: Ka = (9.59 ± 1) × 104 M−1 [1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v), fluorescence]
49 (Ghosh et al. ref. 65) 49. Na-salt of ATP: Ka = 6.80 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, H2O, UV-vis)
49. Na-salt of ADP: Ka = 8.85 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)] 1, H2O, UV-vis)
49. Na-salt of AMP: Ka = 5.96 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, H2O, UV-vis)
50 and 51 (Ghosh et al. ref. 66a) 50. H2PO4: K11 = (2.45 ± 0.1) × 104 M−1, K12 = (2.21 ± 0.1) × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, fluorescence)
50. F: K11 = (1.06 ± 0.08) × 104 M−1, K12 = (8.21 ± 0.8) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, fluorescence)
51. H2PO4: K11 = (2.09 ± 0.16) × 104 M−1, K12 = (1.40 ± 0.12 × 104) M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, fluorescence)
51. F: K11 = (1.84 ± 0.4) × 104 M−1, K12 = (5.19 ± 0.16) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]2, CH3CN, fluorescence)
Anions were used as NnBu4+ salts
53 and 54 (Ghosh et al. ref. 68) 53. L-N-Acetylvaline: Ka = 1.87 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
53. L-N-Acetylalanine: Ka = 2.60 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
53. L-N-Acetylproline: Ka = 1.38 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
53. L-N-Acetylphenylglycine: Ka = 1.31 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
53. AcO: Ka = 2.20 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
53. (S)-Mandelate: Ka = 1.60 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
54. L-N-Acetylvaline: Ka = 1.30 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
54. L-N-Acetylalanine: Ka = 6.50 × 102 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
54. AcO: Ka = 1.70 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
Anions were used as NnBu4+ salts
55 (Ghosh et al. ref. 69) 55. D-Lactate: Ka = (4.17 ± 0.7) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
55. L-Lactate: Ka = (1.92 ± 0.33) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
Anions were used as NnBu4+ salts
56 (Ghosh et al. ref. 70) 56. L-Tartrate: Ka = (6.31 ± 0.056) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
56. D-Tartrate: Ka = (8.18 ± 0.55) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
56. R-Mandelate: Ka = (2.79 ± 0.39) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
56. S-Mandelate: Ka = (2.07 ± 0.22) × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
Anions were used as NnBu4+ salts
61 and 62 (Ghosh et al. ref. 76) 61. F: Ka = 3.14 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3, UV-vis)
61. Cl: Ka = 4.20 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3, UV-vis)
62. F: Ka = 2.07 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CH3CN, fluorescence)
62. F: Ka = 3.21 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, fluorescence)
Anions were used as NnBu4+ salts
63 (Ghosh et al. ref. 77) 77. F: Ka = 8.93 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, DMSO, UV-vis)
Anions were used as NnBu4+ salts
64a (Ghosh et al. ref. 78) 64a. Cl: Ka = 1.31 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 0.2% DMSO, fluorescence)
64a. F: Ka = 3.2 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 0.2% DMSO, fluorescence)
64a. Br: Ka = 3.38 × 103 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 0.2% DMSO, fluorescence)
64a. I: Ka = 3.30 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 0.2% DMSO, fluorescence)
64a. OH: Ka = 2.64 × 104 M−1 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, CHCl3 containing 0.2% DMSO, fluorescence)
Anions were used as NnBu4+ salts


Fabbrizzi et al. reported pyridinium-based structure 6, which includes bound anions such as AcO, H2PO4, and F (taken as tetrabutylammonium salt) in DMSO involving both electrostatic- and hydrogen-bonding interactions.36 In comparison, indole-fused pyridinium compound 7, being less acidic, showed only deprotonation with F and AcO. H2PO4 was complexed in 1[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometric fashion with a log Ka of 3.11.36

image file: c4ra01219d-u2.tif

Steed and co-workers described the synthesis and anion binding properties of a series of 3-aminopyridinium-based tripodal, tricationic hosts 8–11 for anions.37a,b The podand hosts were explored in the binding of halides and oxoanions. The alternating substitution around the central benzene ring preorganizes the hosts in cone conformation. Although the unsubstituted tris (pyridinium) species 8a gives K11 850 M−1 for Br, structure 11 with no ethyl functionality at the core benzene ring shows a binding constant of 17 M−1 for Br ions in CD3CN. This implies the effect of preorganization in the tripods for which the significant degree of cooperativity occurs in binding among the three arms. Among the hosts, the ferrocene appended host 9 exhibited strong binding for Cl (K11 = 17[thin space (1/6-em)]380 M−1) as determined by 1H NMR titration in CD3CN. AcO was complexed with a moderate binding constant (K11 = 3680 M−1) value. In contrast, the anthracene appended tripodal host 10 bound AcO with a high binding constant (K11 = 49[thin space (1/6-em)]000 M−1) value, which was determined in CD3CN by 1H NMR titration. Binding was established through the involvement of N–H and C–H hydrogen bond donation from the arms around the central benzene ring. The same result was realised in the solid state. For example, the X-ray crystal structure of the bromide complex of 8c shows chelation of the Br ion by six fold array of two NH⋯Br and four CH⋯Br interactions (Fig. 2a). In absence of Br, the PF6 salt of 8c assumes non-convergent partial cone conformation, in addition to the engagement of N–H and C–H bonds to fluorine of PF6 ion (Fig. 2b).

image file: c4ra01219d-u3.tif


image file: c4ra01219d-f2.tif
Fig. 2 X-ray crystal structures of the (a) bromide salt of 8c (three-up conformation) and (b) PF6 salt of 8c (partial-cone conformation). Reprinted with permission from ref. 37b. Copyright 2003 American Chemical Society.

Steed et al. also synthesized a series of di-, tri-, and tetrapodal anion-binding hosts—13, 14 and 15, respectively—based on 3-aminopyridinium units with pyrenyl reporter groups.37c The conformational and sensing properties of the hosts were dependent on the spacing and disposition of the binding components. The host 15 bound strongly to dicarboxylates, particularly malonate (log[thin space (1/6-em)]β1 = 5.2 ± 0.1, log[thin space (1/6-em)]β2 = 11.2 ± 0.2), in a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 anion[thin space (1/6-em)]:[thin space (1/6-em)]host ratio in CH3CN and exhibited fluorescence quenching as a result of pyrene–pyridinium charge-transfer interaction in the excited state. The higher value of the second equilibrium constant than the first indicates that complexation of the first anion favours complexation of the second anion on the opposite side of the calixarene ring through allosteric conformational changes. The host also preferred Cl ion over the other monovalent anions, but the association constant for dicarboxylate was at least an order of magnitude higher than that for halides despite the fact that a fluorescent response was observed only upon Cl ion binding. In contrast, host 14 showed the highest association constants (for 1[thin space (1/6-em)]:[thin space (1/6-em)]1 and 2[thin space (1/6-em)]:[thin space (1/6-em)]1 adducts) for Cl, while 13 bound strongly to AcO ion.

image file: c4ra01219d-u4.tif

However, urea-containing tripodal receptors 16 and 17 reported by Steed and coworkers38 proved to be effective anion-binding hosts and represented an improvement over the amine-based systems. The urea motifs were observed for complex anions along with crystallizing solvents as supported by X-ray crystal structures. The X-ray crystal structures of 16 containing different counter anions represent the various geometries of host (Fig. 3). To determine the binding efficacy in solution, the binding constant values were determined from 1H NMR in d6-DMSO. Selectivity for H2PO4 was observed over a series of anions such as Cl, Br, I, NO3, AcO, HSO4, CF3SO3 and ReO4. Log binding constants for the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 and 1[thin space (1/6-em)]:[thin space (1/6-em)]2 host/guest complexes with H2PO4 were found to be 3.70 and 3.68, respectively. The values of binding constants obtained with 16 in d6-DMSO were modest due to the highly polar nature of the solvent. However, titrations of the more soluble octyl-substituted host 17 in CD3CN exhibited larger binding constants (Table 1). On the basis of experimental observations, Steed et al., further reported the occurrence of at least two binding processes during the halide titration. The first equivalent of the guest gave rise to a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 complex, in which the value of K11 was, in all cases, higher than K12 and K13. This indicated that the initial binding event may be due to chelation of the guest by the three arms, followed by cases in which each anion binds to a separate arm.

image file: c4ra01219d-u5.tif


image file: c4ra01219d-f3.tif
Fig. 3 X-ray crystal structures of (a) bromide salt of 16 (three-up conformation), (b) acetone solvate of PF6 salt of 16 (complexed acetone), and (c) NO3 complex of 16. Reprinted with permission from ref. 38. Copyright 2006 American Chemical Society.

In continuation, two new tripodal “pinwheel” type anion binding hosts based on a triethylbenzene core and bipyridinium unit 18a–b were also reported by Steed et al.39 These hosts complexed anions only via CH⋯anion interaction, which was established by their crystal structures (Fig. 4a). Packing of the molecules revealed interhost stacking (Fig. 4b). 1H NMR titration of tripod 18a with disodium salt of ATP in D2O/CD3CN (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) resulted in significant changes to the pyridyl proton resonances. A good fit to the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 binding model gave the binding constant value of 70 M−1. The influence of charge–charge and π-stacking interactions played a crucial role in this recognition process.


image file: c4ra01219d-f4.tif
Fig. 4 Crystal structures of (a) 18a and 18b (reproduced from ref. 39).

When the triethylbenzene core is replaced by the calixarene unit, pyridinium-based hosts are found to be versatile in anion binding. Two types of calix[4]arene derived pyridinium-based hosts 19a–d and 20a–d were reported by Steed et al.40

image file: c4ra01219d-u6.tif

Interestingly, although the 1,3-alternate system 19 bound dicarboxylate anions in a ditopic manner following a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 guest[thin space (1/6-em)]:[thin space (1/6-em)]host ratio, the cone compound 20 was deprotonated by carboxylates. The ditopic 1,3-alternate host 19c binds malonate with Ka = 58[thin space (1/6-em)]800 M−1 in CH3CN–DMSO (60[thin space (1/6-em)]:[thin space (1/6-em)]40, v/v) with a 1[thin space (1/6-em)]:[thin space (1/6-em)]2 (host[thin space (1/6-em)]:[thin space (1/6-em)]guest) ratio. The malonate anions were chelated by a pairs of pyridinium arms via NH⋯O and CH⋯O interactions, as shown in Fig. 5. In contrast, due to lack of cooperativity between the arms, the cone compounds bound small spherical anions. They strongly bind Br and NO3 ions.


image file: c4ra01219d-f5.tif
Fig. 5 Binding structure of 19c with malonate.

In lieu of 3-aminopyridine, quaternary bispyridinium and polypyridinium compounds 21–22 were also employed in anion binding.41 1H NMR studies in d6-DMSO revealed that the compounds have an affinity for Cl ions. Of the different structures, tripodal structure 22b showed the strongest affinity for Cl ions (Ka = 110 M−1). Electrochemical study revealed that due to the presence of redox active 4,4′-bipyridinium moiety, structure 22a exhibited a significant cathodic shift upon the addition of Cl ions (ΔE = 130 mV).

image file: c4ra01219d-u7.tif

Tuning of the structural features of polypyridinium compounds introduced new viologen-based receptors 23–24.42 The NMR titration results in CD3CN revealed that the hosts bound to two Cl ions with log[thin space (1/6-em)]K11 = 3.95 and log[thin space (1/6-em)]K12 = 3.21 for 23, and log[thin space (1/6-em)]K11 = 3.55 and log[thin space (1/6-em)]K12 = 3.39 for 24. Interestingly, binding of carboxylate anions, particularly acetate, malonate and succinate by pyridinium derivative 23 in CH3CN resulted in an intense purple colouration (Fig. 6a). Theoretical calculation on the representative system 23.malonate revealed that the origin of color was due to charge-transfer from the anion to the bipyridinium unit. In contrast, anion binding by 24 did not initially result in colour change because anions were complexed at the periphery of the receptor. However, the addition of more than two equivalents of acetate, or more than one equivalent of dicarboxylates gave intense pink color (Fig. 6b).


image file: c4ra01219d-f6.tif
Fig. 6 Change in color of the host solutions (c = 1 × 10−4 M): (a) host 23 in the presence of one equivalent of tetrabutylammonium succinate, malonate, acetate, chloride, bromide, nitrate and perrhenate (from left to right); (b) host 24 with four equivalents of the same anions (from left to right). Reproduced from ref. 42 with permission from the Centre National de la Recherche Scientifique (CNRS) and The Royal Society of Chemistry.

Our group exhaustively used the pyridinium motif in building up a series of synthetic receptors that showed potentiality in anion binding. Simple design 25 from our group strongly bound basic anions such as AcO, H2PO4 and F with an affinity constant on the order of 104 M−1 in CH3CN.43 Analysis of the fluorescence behaviour of 25 towards a series of anions interpreted that the cleft of 25 can distinguish aliphatic carboxylates from aromatic carboxylates and is also able to report the selective binding of tetrahedral-shaped H2PO4 ions through strong excimer formation between the pendant anthracenes.

image file: c4ra01219d-u8.tif

The change of isophthaloyl spacers in 25 by biphenyl units led to a new structure 26 that showed selective complexation of isophthalate and H2PO4.44 The addition of H2PO4, HSO4 and isophthalate to the solution of 26 in CHCl3 containing 2% CH3CN caused changes in monomer emission of anthracene followed by the appearance of an excimer. The greater intensity of the excimer emission in the presence of H2PO4 distinguished it from the other anions. Analysis of the fluorescence titration results revealed the Ka value of 1.22 × 104 M−1 for H2PO4. It is notable that such anthracene-labelled bispyridinium diamide not only showed propensity for dihydrogen phosphate sensing but also exhibited good interaction with DNA. The compounds of this class are cell permeable and useful for cell staining.45

image file: c4ra01219d-u9.tif

The tuning of structure 25 was further done in our laboratory by macrocyclisation. The synergistic effect of hydrogen bonding, weak π-stacking and charge–charge interactions enabled the macrocycle 27 to complex 1,4-phenylenediacetate (Ka = 3.34 × 105 M−1) selectively. During complexation, a considerable increase in anthracene emission was observed.46

image file: c4ra01219d-u10.tif

Referring to our work on 25, Yatsimirsky and co-workers reported a series of known isomeric dicationic N-methylated pyridyl derivatives47 (28–30) of three isomers of N,N′-bis(pyridyl)-2,6-pyridine dicarboxamide 31–33.47 The binding of the cationic compounds were studied and compared with the neutral analogues. Cationic receptors offered higher affinity and selectivity for anions in CH3CN (log[thin space (1/6-em)]K in the range 3.5–6.5) than their corresponding neutral versions. Indeed, the dicationic compounds showed pronounced selectivity for Cl ions and in some cases for AcO.47 The stoichiometry of the complexes was established as 1[thin space (1/6-em)]:[thin space (1/6-em)]1 and also 1[thin space (1/6-em)]:[thin space (1/6-em)]2 (host[thin space (1/6-em)]:[thin space (1/6-em)]guest), which varied with the isomer. The solid-state binding of the three isomers was also highlighted by Yatsimirsky and co-workers. An analysis of four crystal structures of chloride and triflate complexes of the three isomers revealed anion binding in the cleft involving amide NH and CH interactions.

image file: c4ra01219d-u11.tif

On the other hand, based on the observation of receptor 25, Gong et al. reported a tripodal fluorescent chemosensor 34 with 3-aminopyridinium as a binding motif for H2PO4.48 Upon complexation of H2PO4, the tripodal receptor 34 in CH3CN/EtOH (9[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) gave a strong excimer, which was diagnostic to distinguish H2PO4 from the other anions. In continuation, the same group reported another chemosensor 35 by changing the spacer. The dipodal sensor 35 exhibited solvent polarity-dependant conformational behaviour. They proposed that intramolecular hydrogen bonding of the pyridinium ortho proton with the amide carbonyl oxygen regulated the cleft dimension, and in both CHCl3 and CH3CN, the sensor 35 selectively sensed H2PO4.49a

image file: c4ra01219d-u12.tif

In addition, Gong et al. synthesized dipodal49b and tripodal49c receptors for colorimetric sensing of AcO over a series of other anions based on the utilization of amide–pyridinium as a recognition site, and nitro-benzene as a signalling unit. The addition of AcO induced clear color change of the receptor solutions from colorless to yellow.

The rational design of unsymmetrical bispyridinium amide is another strategy with which to make an anion-binding host. Furthermore, we reported the hetero bisamide 36 in 2011, which selectively recognised tetrabutylammonium benzoate over a range of aliphatic monocarboxylates in CHCl3 containing 2% CH3CN by showing concomitant increase in pyrene emission. The hydrogen bonding, charge–charge interaction and the π-stacking effect as displayed in Fig. 7 corroborated the selective sensing of benzoate (Ka = 3.46 × 103 M−1). Moreover, the cleft of 36 showed selective sensing of HSO4 (Ka = 1.87 × 103 M−1) over the H2PO4 ion by exhibiting considerable change in emission of 36.50


image file: c4ra01219d-f7.tif
Fig. 7 Suggested benzoate complex of 36.

In continuation, we addressed another hetero bisamide 37 that contains anthracene in a selective position to create a PET (photoinduced electron transfer) sensor.51 The fluorescent hetero bisamide 37 exhibited selective binding of monocarboxylates over their conjugate acids in spite of the presence of binding complementarity to both carboxylate and carboxylic acid (Fig. 8).


image file: c4ra01219d-f8.tif
Fig. 8 Possible modes of complexation of 37 with carboxylates and carboxylic acids.

Binding analysis indicated that AcO (Ka = 1.16 × 104 M−1) and CH3CH2COO (Ka = 1.04 × 104 M−1) anions were preferred in the cleft over their conjugate acids by giving significant change in emission (Fig. 9).


image file: c4ra01219d-f9.tif
Fig. 9 Change in fluorescence ratio of 37 (c = 6.27 × 10−5 M) at 412 nm upon addition of two equivalents of guests in CH3CN. Reprinted with permission from ref. 51. Copyright 2011 Taylor & Francis.

Of the different solvent combinations, 2% CH3CN in CHCl3 was a better choice for improved selectivity in the recognition process. While the emission of 37 upon addition of aliphatic carboxylate guest in CH3CN was perturbed to a lesser extent, it was found to be significant with a new emission at ∼512 nm in the less polar solvent CHCl3 containing 2% CH3CN. Fig. 10 illustrates this aspect. The binding affinity of the cleft of 37 for anions was further realized from the analysis of global electrophilic characters by using the DFT calculation.51


image file: c4ra01219d-f10.tif
Fig. 10 Change in emission of 37 (c = ∼10−5 M) upon addition of (a) propanoate in CH3CN and (b) acetate in CHCl3 containing 2% CH3CN. Reprinted with permission from ref. 51. Copyright 2011 Taylor & Francis.

The carboxylate binding affinity of the cleft of hetero bis amides as previously discussed was further used in our laboratory in the selective sensing of tetrabutylammonium salt of biotin (Ka varies in between 102 M−1 and 104 M−1) over the biotin ester by naphthyridine-appended pyridinium salts 38 and 39.52 Biotin is an essential co-factor for a number of enzymes that have diverse metabolic functions.53 Despite not using fluorophore, the emission feature of naphthyridine was used to assess the binding characteristics. The diamide clefts of the receptors bound carboxylate functionality involving NH⋯O, CH⋯O hydrogen bonds and charge–charge interactions. The bicyclic urea part of biotin was complexed by the pendant naphthyridine motifs due to which emission of naphthyridine was considerably enhanced. The fluorometric titration was conducted in CH3CN containing 1.2% DMSO. Binding was also determined by 1H NMR titration. The unsymmetrical receptor 38 gave improved binding over the symmetrical diamide 39. The less steric feature at the naphthyridine site in 38 allowed for comfortable binding of the bicyclic urea part of biotin.

image file: c4ra01219d-u13.tif

In an effort to recognise dicarboxylates (larger anions), the ureidopyridyl groups were coupled with anthracene units to make chemosensor 40. 1H NMR, fluorescence and UV-vis studies established the compound 40 as a selective sensor for 1,4-phenylenediacetate (log[thin space (1/6-em)]K = 8.93) over a series of other aliphatic dicarboxylates in DMSO.54

image file: c4ra01219d-u14.tif

Based on this observation, we further moved to another new system 41 where the ureidopyridyl unit is replaced by trans-pyridylcinnamide. The trans-pyridylcinnamide motif was used as an alternative of urea to form a hydrogen-bonded complex with the carboxylate in the mode shown in Fig. 11. However, the sensor 41 showed moderate selectivity for long-chain pimelate over a wide range of dicarboxylates by exhibiting good fluorescence ‘On-Off’ switchability. The switching mode was noted to be the reverse of that in the urea analogue 40. The interplay of N–H⋯O, C–H⋯O hydrogen bonds and charge–charge interactions contribute to selectivity in the recognition process.55


image file: c4ra01219d-f11.tif
Fig. 11 Hydrogen-bonded complexes of carboxylate with (a) cinnamide and (b) urea derivatives.

Rather than anthracene, triphenylamine was used in building up pyridinium-based ditopic receptors 42 for dicarboxylates.56 In the design, the triphenylamine acts as a spacer as well as fluorescent probe to illustrate the recognition process. From fluorescence titration, the open cleft of receptor 42 was selective for pimelate (log[thin space (1/6-em)]K = 5.00 ± 0.01). Upon complexation (suggested mode shown in Fig. 12), the emission intensity gradually decreased to the significant extent. Under comparitively similar conditions, the pyridine-N-oxide analogue 43 was less efficient in the recognition process. This experimental fact indicated the greater electrophilic characteristic of the pyridinium amide for the complexation of anion. This was further explained by calculating the global electropilicity by using the DFT calculation.


image file: c4ra01219d-f12.tif
Fig. 12 Suggested binding mode of dicarboxylate in the cavity of 42.

The variation of the synthetic spacer in the designed-molecule draws attention. The placement of pyridinium motifs on ortho-phenylenediamide core resulted in compound 44,57 which selectively bound H2PO4 in CH3CN, giving excimer emission at 456 nm due to π–π stacking between the pendant naphthalene units. The sensor 44 also fluorometrically distinguished ATP from ADP and AMP in CH3CN–H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) at pH 6.5 by exhibiting a more intense band of exciplex formed due to favorable stacking of the adenine ring in between the pendant naphthalenes (Fig. 13).


image file: c4ra01219d-f13.tif
Fig. 13 Possible binding structure of 44 with ATP.

The pyridinium-based architectures were also used in the indicator displacement assay (IDA) technique for anion sensing. In this technique, an indicator is first allowed to bind reversibly to a receptor and then a competitive analyte is introduced into the system causing the displacement of the indicator from the host which in turn modulates the optical signal.58 Pyridinium-based symmetrical receptors 45 and 46 were first applied in the IDA technique for the selective sensing of carboxylate guests.59

image file: c4ra01219d-u15.tif

Both the receptors responded in CH3CN/H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) at pH 6.3 for the selective naked-eye detection of citrate over a series of guests. Additionally, receptor 46 (c = 6.29 × 10−3 M) formed stable gel selectively with citrate in CH3CN. It was proposed that conventional N–H⋯O and unconventional C–H⋯O hydrogen bonds, charge–charge interactions and pyrene with large π-surface interplayed together to set up a network in solution in the presence of citrate for which gelation occurred. The non-responsive behaviour of 45 in the formation of the gel indicated the role of pyrene in 46. However, both the receptors gave binding constant values on the order of 104 M−1 with 1[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometry.

Using the IDA technique, tetrabutylammonium hydrogenpyrophosphate was recognized over a series of other anions in both CH3CN and aqueous CH3CN (CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O = 4[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v, pH = 6.5) by receptor structures 47 and 48.60 In the unsymmetrical receptors, pyridinium motifs were manipulated by using 3-picolinic acid. Compound 47 showed a binding constant value of (9.59 ± 1) × 104 M−1 for HP2O73−. However, the Merrifield resin-supported bead 48 was of practical use to naked-eye detection of HP2O73− in CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (4[thin space (1/6-em)]:[thin space (1/6-em)]1 v/v), as well as in pure water at pH 6.5 via the IDA technique. Moreover, the experiments with blood serum suggest that the sensor bead 48 is capable of sensing HP2O73− selectively in complex biological systems. It is notable that the selective detection of hydrogen pyrophosphate or pyrophosphate (PPi) is an important aspect in supramolecular chemistry research. PPi is a biologically important target that arises from ATP hydrolysis under cellular conditions.61 It is involved in DNA sequencing/replication62 and has physiological relevance in energy storage and signal transduction. Therefore, the detection of PPi has become important in cancer research.62,63 Patients with calcium pyrophosphate dehydrate (CPPD) crystals and chondrocalcinosis are generally found to have high synovial fluid PPi levels.64

image file: c4ra01219d-u16.tif

Following the IDA technique through the use of uranine dye, a water-soluble tripodal receptor 49 was established from our laboratory as a chemosensor for naked-eye recognition of AMP (Ka = 5.96 × 103 M−1) over ADP and ATP in aqueous environment.65 Complexation of AMP was supported by both experimental and theoretical investigations. Furthermore, the tripod was used to recognise the intercellular AMP as well as the ALP-mediated conversion of ATP/ADP via the IDA technique.

image file: c4ra01219d-u17.tif

In addition, modification of the substituent of pyridine ring nitrogen by using 1,2,3-triazole ring, which is surrogate of amide, was performed, and the structure 50 was synthesized in our laboratory. The receptor structure 50 selectively recognized H2PO4 by exhibiting ratiometric change in emission and formed a stable gel in CHCl3 containing 10% CH3CN. This was useful for visually sensing of H2PO4.66a In comparison, receptor 51, which is devoid of a triazole motif, did not form a gel with H2PO4 under similar conditions. Upon interaction with H2PO4, the intensity of monomer- and excimer-emission peaks of 51 increased markedly without giving any ratiometric nature in the spectra. Moreover, F ion-induced greater quenching of monomer emissions in both 50 and 51 in a non-ratiometric manner distinguished it from other anions examined. These observations underlined the key role of the triazole ring in 50 in anion recognition. Indeed, a triazole is a well-established motif in anion binding.66b Job's plot analysis of the flourescence titration spectra gave a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 (guest[thin space (1/6-em)]:[thin space (1/6-em)]host) complex between H2PO4 and 50. This was also true for F. On the basis of 2[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometry in the excited state, the association constants of 50 for H2PO4 and F were established to be (K11 = 2.45 ± 0.1 × 104 M−1, K12 = 2.21 ± 0.1 × 104 M−1) and (K11 = 1.06 ± 0.08 × 104 M−1, K12 = 8.21 ± 0.8 × 103 M−1), respectively. The receptor 51 followed 2[thin space (1/6-em)]:[thin space (1/6-em)]1 (guest[thin space (1/6-em)]:[thin space (1/6-em)]host) binding stoichiometries with both H2PO4 and F in an excited state similar to that of 50 and gave relatively lower binding constant values [(K11 = 2.09 ± 0.16 × 104 M−1, K12 = 1.40 ± 0.12 × 104 M−1 for H2PO4) and (K11 = 1.84 ± 0.40 × 104 M−1, K12 = 5.19 ± 0.16 × 103 M−1 for F)].

image file: c4ra01219d-u18.tif

Following modification, pyridinium-based receptor modules have been used to bind zwitterionic α-amino acids. In this context, Jeong et al. made a new simple compound 52 that is composed of two components, namely benzo-18-crown-6 and a urea functionality for binding the ammonium and carboxylate groups of zwitterionic α-amino acids (52a), respectively.67 They examined the amino acid-binding property by solid–liquid and liquid–liquid extractions at 24 ± 1 °C and also applied it in the transportation of amino acids across a CHCl3 liquid membrane. The transport efficiency was established as Phe > Trp > Ile > Leu > Val ≫ Ala > Ser ≫ Asp, His.

image file: c4ra01219d-u19.tif

For fluorometric sensing of a particular α-amino acid derivative, pyridinium amide was used in conjunction with the urea motif by our group using the PET sensor 53.68 Fluorescence studies of 53 in CH3CN (λex = 370 nm) revealed a moderate quenching of the emission at 415 nm upon addition of L-N-acetylproline, (S)-mandelate, pyruvate, and L-N-acetylglycine, whereas L-N-acetylalanine and L-N-acetylvaline resulted in an increase of emissions, including the appearance of a broad emission of moderate intensity at 492 nm. The peak at 492 nm, which was more significant in presence of L-N-acetylvaline than L-N-acetylalanine, was attributed to the formation of a charge-transfer complex between the excited state of anthracene and the electron-deficient nitrophenyl urea. This was confirmed by considering the amide–amide analogue 54. Fluorometric titrations revealed 1[thin space (1/6-em)]:[thin space (1/6-em)]1 binding of L-N-acetylvaline (Ka = 2.60 × 103 M−1) with receptor 53 in CH3CN.

image file: c4ra01219d-u20.tif

The attachment of a chiral amide or urea segment to the side chain of the 3-aminopyridinium unit resulted in chiral sensors such as 55 and 56. The chiral receptors were found to be useful in chiral recognition of hydroxyl carboxylates such as lactate and tartrate.

image file: c4ra01219d-u21.tif

A synthetic fluorescent chemosensor that discriminates the enantiomers of a particular chiral guest by exhibiting different fluorescence behaviors draws attention in the area of molecular recognition. The simple pyridinium-based chiral receptor 55 containing L-valine as the chiral source fluorometrically recognizes D-lactate [(Ka = 4.17 ± 0.7) × 103 M−1] over L-lactate in CH3CN with enantiomeric fluorescence ratio (ef) of 5.32.69 While upon gradual addition of D-lactate to the solution of 55 the monomer emission at ∼400 nm increases significantly, a small emission increase with the addition of L-lactate was observed. Similarly, by using L-valine as a chiral source, an anthracene-based chiral chemosensor 56 was established as an efficient enantioselective sensor for L-tartrate (ef = 29.38) over D-tartrate in DMSO.70 In the presence of tetrabutylammonium salt of L-tartaric acid, the monomer emission of 56 at 432 nm was considerably enhanced giving a binding constant value of (6.31 ± 0.05) × 103 M−1.

The versatility of pyridinium motifs in molecular recognition is commendable. It cannot be completed if its use in gel chemistry is not discussed. Gels are considered as viscoelastic solid- or liquid-like materials (called gelators), comprised of cross-linked networks and a solvent, which was the major component. Multiple non-covalent interactions among the gelators are critical to establish the network in solution. For this, several functional groups are identified in gelator molecules. Amide, hydroxyl and urea groups are generally incorporated into the structures of gelators for the formation of self-associated chains that contribute to the gelation of solvent molecules.71 In 2003, Kato et al. reported some pyridyl ureas that acted as gelators and produced fibrous self-assembly.72 Dostidar and co-workers investigated the gelation properties of the pyridyl ureas such as 57, 58 and 59.73 Among the three, only compound 57 exhibited gelation ability in pure water. The isomeric compounds 58 and 59 are non-gelators. A theoretical calculation on this aspect was recently performed by Xie et al.74 They studied the conformational and hydrogen-bonding behaviours of the three isomers (57, 58 and 59) in detail.

image file: c4ra01219d-u22.tif

Bispyridyl ureas 60 with flexible linkers generally did not show any gelation property. However, upon interaction with both Ag+ and Cu2+ salts, they exhibited gelation tendency. Metal-induced cross linking introduced gelation of the systems.75

image file: c4ra01219d-u23.tif

Besides the metal ions, the introduction of the cholesteryl unit onto the pyridine ring nitrogen in the dipyridyl urea 58 modified its gelation property. In relation to this, the compound 61 exhibited gelation in CHCl3;76 the gel was anion responsive. In the presence of F, the gel state was transformed into the sol and validated the visual sensing of F. Conversely, unsymmetrical pyridyl urea salt 62 fluorimetrically distinguished F from the other anions in both CH3CN and DMSO with appreciable binding constant values.76 It is noteworthy that the compound 62 formed gel in DMSO in the presence of F, whereas the compound 61 underwent a transition from gel to sol state in CHCl3 in the presence of same anion. Generally, anions are gel breakers, but the appearance of the gel in the presence of F in the case of 62 is noteworthy. We explained this due to the effective aggregation of gelators. The dianionic species obtained from fluoride-induced deprotonation of urea motifs in 62, and the resulting HF2 are involved in intermolecular contacts to set up a network in solution. The stabilization of the network is influenced by a large hydrophobic surface of the cholesterol moiety. The replacement of the coumarin substituent in 62 by nitrophenyl motif resulted in a similar type of compound 63, which acted as low-molecular weight gelator in DMSO[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) in the presence of F (Fluoride source: KF, NaF, CsF and tetrabutylammonium fluoride).77 During gelation, the color change was useful in naked-eye detection of F. The deprotonation of urea protons and subsequent delocalization of the charge to the nitrophenyl motif introduced the color change. Furthermore, the gel state was reported to be a good semiconductor, in addition to a medium to detect Cu2+ and Pb2+ ions by showing a transition from gel to sol.

image file: c4ra01219d-u24.tif

Like pyridinium ureas, cholesterol appended pyridinium amides were found to be noteworthy as low molecular weight gelators. Recently, we have demonstrated that cholesterol-appended pyridinium diamide 64 gives instant gel from chloroform.78 The gel is pH-responsive and exhibits ionic conductivity due to the movement of unrestricted Cl ions within the network. The gel acted as a media to recognize Ag+ ion over a series of other cations by exhibiting gel-to-sol transformation. The gel state reappeared in the presence of chloride salt and indicated reversibility in the process. It was further observed that hexafluorophosphate analogue 64a which was obtained from 64 on anion exchange, allowed the selective recognition of Cl over other halides by forming transparent yellow-colored gel in CHCl3.

image file: c4ra01219d-u25.tif

Conclusion

Significant progress in the design and synthesis of receptors (both non fluorescent and fluorescent) of various architectures based on pyridinium motif has been made during the past several years. The use of 3-aminopyridine and related derivatives has provided various strategies for the design of chemosensors for the recognition of anions, including halides, phosphate derivatives, phosphate-based nucleotides, DNA, and dicarboxylates. In addition, the enantioselective sensing of hydroxyl carboxylates by pyridinium-based chiral fluororeceptors has been explored. Further, it has been observed that the incorporation of hydrophobic surfaces into pyridinium-based urea or amide receptors draws considerable attention as the compounds of this class are useful in gel chemistry. Gels are stimuli-responsive and highly appealing in anion recognition. Although an increasing number of receptors/probes have been developed on the basis of a 3-aminopyridine unit, further developments in the fabrication of new sensing systems, including chiral receptors, stimuli-responsive gelators, and nano particle-hooked sensors, with high sensitivity and selectivity are still in demand. Moreover, in continuation of our work on the systems 47 and 48, there is sufficient scope to use 3-aminopyridine to develop solid-supported receptor beads that are useful for detecting anions in an aqueous environment.

Acknowledgements

We thank DST [Project no. SR/S1/OC-76/2010(G); Date: 23.08.2011] New Delhi, India, for financial support. T.S., S.P. and D.K. thank CSIR, New Delhi, India, for a fellowship.

References

  1. A. P. deSilva, H. Q. N. Gunaratne, T. Gunnalangsson, A. J. M. Huxley, C. P. McCoy, J. T. Rademacher and T. E. Rice, Chem. Rev., 1997, 97, 1515 CrossRef CAS PubMed .
  2. R. Martinez-Manez and F. Sancenon, Chem. Rev., 2003, 103, 4419 CrossRef CAS PubMed .
  3. C. Caltagirone and P. A. Gale, Chem. Soc. Rev., 2009, 38, 520 RSC .
  4. J. W. Steed, Chem. Soc. Rev., 2009, 38, 506 RSC .
  5. Y. Hua and A. H. Flood, Chem. Soc. Rev., 2010, 39, 1269 RSC .
  6. A. E. Hargrove, S. Nieto, T. Zhang, J. L. Sessler and E. V. Anslyn, Chem. Rev., 2011, 111, 6603 CrossRef CAS PubMed .
  7. M. Wenzel, J. R. Hiscock and P. A. Gale, Chem. Soc. Rev., 2012, 41, 480 RSC .
  8. L. E. Santos-Figueroa, M. E. Moragues, E. Climent, A. Agostoni, R. Martinez-Manez and F. Sancenon, Chem. Soc. Rev., 2013, 42, 3489 RSC .
  9. C. H. Park and H. E. Simmons, J. Am. Chem. Soc., 1968, 90, 2431 CrossRef CAS .
  10. J.-M. Lehn, E. Sonveaux and A. K. Wilard, J. Am. Chem. Soc., 1978, 100, 4914 CrossRef CAS .
  11. J. P. Kintzinger, J.-M. Lehn, E. Kauffmann, J. L. Dye and A. I. Popov, J. Am. Chem. Soc., 1983, 105, 7549 CrossRef CAS .
  12. B. Dietrich, T. M. Fiyles, J.-M. Lehn, L. G. Pease and D. L. Fyles, J. Chem. Soc., Chem. Commun., 1978, 934 RSC .
  13. G. Muller, J. Riede and F. P. Schmidchen, Angew. Chem., Int. Ed., 1998, 27, 1516 CrossRef .
  14. J. Yoon, S. K. Kim, N. J. Sing and K. S. Kim, Chem. Soc. Rev., 2006, 35, 355 RSC .
  15. Z. C. Xu, S. K. Kim and J. Yoon, Chem. Soc. Rev., 2010, 39, 1457 RSC .
  16. Z.-Y. Dong, X.-Z. Jiang, Y.-R. Xue, M.-Y. Feng and G.-H. Gao, Chem. Res. Chin. Univ., 2011, 32, 2032 CAS .
  17. Y. Bai, B.-G. Zhang, J. Xu, C.-Y. Duan, D.-B. Dang, D.-J. Liu and Q.-J. Meng, New J. Chem., 2005, 29, 777 RSC .
  18. Y. Bai, B.-G. Zhang, C.-Y. Duan, D.-B. Dang and Q.-J. Meng, New J. Chem., 2006, 30, 266 RSC .
  19. V. K. Khatri, M. Chahar and K. Parani, J. Org. Chem., 2007, 72, 10224 CrossRef CAS PubMed .
  20. K. Ghosh and D. Kar, Beilstein J. Org. Chem., 2011, 7, 254 CrossRef CAS PubMed .
  21. K. Ghosh, I. Saha, R. Frohlich and A. Patra, Mini-Rev. Org. Chem., 2011, 8, 31 CrossRef CAS .
  22. Z. Y. Dong and G. Giotto, Chin. Sci. Bull., 2012, 57, 1266 CrossRef CAS PubMed .
  23. K. Ghosh and I. Saha, Org. Biomol. Chem., 2012, 10, 9383 CAS .
  24. K. Ghosh, S. S. Ali and S. Joardar, Tetrahedron Lett., 2012, 53, 2054 CrossRef CAS PubMed .
  25. D. Zhang, X. Jiang, H. Yang, Z. Su, E. Gao, A. Martinez and G. Gao, Chem. Commun., 2013, 49, 6149 RSC .
  26. B. Dietrich, J. Guilhem, J.-M. Lehn, C. Pascard and E. Sonveaux, Helv. Chim. Acta, 1984, 67, 91 CrossRef CAS .
  27. M. Boiocchi, M. Bonizzoni, L. Fabbrizzi, G. Piovani and A. Taglietti, Angew. Chem., Int. Ed., 2003, 125, 9699 Search PubMed .
  28. W.-S. Yeo and J.-I. Hong, Tetrahedron Lett., 1998, 39, 8137 CrossRef CAS .
  29. W. B. Bell and N. M. Hext, Chem. Soc. Rev., 2004, 33, 589 Search PubMed .
  30. M. Orlowska, M. Mroczkiewicz, K. Guzow, R. Ostaszewski and A. M. Klonkowski, Tetrahedron, 2010, 66, 2486 CrossRef CAS PubMed .
  31. R. Tayor and O. Kennard, J. Am. Chem. Soc., 1982, 104, 5063 CrossRef .
  32. V. R. Pedireddi, W. Jones, A. P. Chorlton and R. Docherty, J. Chem. Soc., Chem. Commun., 1996, 997 RSC .
  33. C. V. K. Sharma and M. J. Zaworotko, J. Chem. Soc., Chem. Commun., 1996, 2655 RSC .
  34. S. Tomas, R. Prohens, M. Vega, M. C. Rotger, P. M. Deya, P. Ballester and A. Costa, J. Org. Chem., 1996, 61, 9394 CrossRef CAS .
  35. K.-S. Jeong and Y. L. Cho, Tetrahedron Lett., 1997, 38, 3279 CrossRef CAS .
  36. V. Amendola, M. Boiocchi, L. Fabbrizzi and A. Ralchetti, Chem.–Eur. J., 2005, 11, 120 CrossRef PubMed .
  37. (a) J. W. Steed, Chem. Commun., 2006, 2637 RSC ; (b) K. J. Wallace, W. J. Belcher, D. R. Turner, K. F. Syed and J. W. Steed, J. Am. Chem. Soc., 2003, 125, 9699 CrossRef CAS PubMed ; (c) M. H. Fiby, S. J. Dickson, N. Zaccheroni, L. Prodi, S. Bonacchi, M. Montalti, M. J. Paterson, T. D. Humphries, C. Chiorboli and J. W. Steed, J. Am. Chem. Soc., 2008, 130, 4105 CrossRef PubMed .
  38. D. R. Turner, M. J. Paterson and J. W. Steed, J. Org. Chem., 2006, 71, 1598 CrossRef CAS PubMed .
  39. W. J. Belcher, M. Fabre, T. Farhan and J. W. Steed, Org. Biomol. Chem., 2006, 4, 781 CAS .
  40. M. H. Filby, T. D. Humphries, D. R. Turner, R. Kataky, J. Kruusma and J. W. Steed, Chem. Commun., 2006, 156 RSC .
  41. P. D. Beer, N. C. Fletcher, A. Grieve, J. W. Wheeler, C. P. Moore and T. Wear, J. Chem. Soc., Perkin Trans. 2, 1996, 1545 RSC .
  42. S. J. Dickson, E. V. B. Wallace, A. N. Swinburne, M. J. Paterson, G. O. Lloyd, A. Beeby, W. J. Belcher and J. W. Steed, New J. Chem., 2008, 32, 786 RSC .
  43. K. Ghosh, A. R. Sarkar and G. Masanta, Tetrahedron Lett., 2007, 48, 8725 CrossRef CAS PubMed .
  44. K. Ghosh, A. R. Sarkar and A. Patra, Tetrahedron Lett., 2009, 50, 6557 CrossRef CAS PubMed .
  45. K. Ghosh, A. R. Sarkar, A. Ghorai and U. Ghosh, New J. Chem., 2012, 36, 1231 RSC .
  46. K. Ghosh and A. R. Sarkar, Tetrahedron Lett., 2009, 50, 85 CrossRef CAS PubMed .
  47. A. Dorazco-Gonzalez, H. Hopfl, F. Medrano and A. K. Yatsimirsky, J. Org. Chem., 2010, 75, 2259 CrossRef CAS PubMed .
  48. W.-T. Gong and K. Hiratani, Tetrahedron Lett., 2008, 49, 5655 CrossRef CAS PubMed .
  49. (a) W.-T. Gong, S. Bao, E.-R. Wang, J.-W. Ye, G.-L. Ning and K. Hiratani, Tetrahedron Lett., 2011, 52, 630 CrossRef CAS PubMed ; (b) W.-T. Gong, B. Gao and S. Bao, J. Inclusion Phenom. Macrocyclic Chem., 2012, 72, 481 CrossRef CAS ; (c) S. Bao, W.-T. Gong, W.-D. Chen, J.-W. Ye, Y. Lin and G.-I. Ning, J. Inclusion Phenom. Macrocyclic Chem., 2011, 70, 115 CrossRef CAS .
  50. K. Ghosh and A. R. Sarkar, Supramol. Chem., 2011, 23, 365 CrossRef CAS .
  51. K. Ghosh and A. R. Sarkar, Supramol. Chem., 2011, 23, 539 CrossRef CAS .
  52. K. Ghosh, A. R. Sarkar and T. Sen, Supramol. Chem., 2010, 22, 81 CrossRef CAS .
  53. D. L. Nelson and M. M. Cox, Lehninger Principles of Biochemistry, Worth Publishers, New York, 3rd edn, 2000 Search PubMed .
  54. K. Ghosh, G. Masanta and A. P. Chattopadhyay, Tetrahedron Lett., 2007, 48, 6129 CrossRef CAS PubMed .
  55. K. Ghosh and G. Masanta, Tetrahedron Lett., 2008, 49, 2592 CrossRef CAS PubMed .
  56. K. Ghosh, G. Masanta and A. P. Chattopadhyay, Eur. J. Org. Chem., 2009, 4515 CrossRef CAS .
  57. K. Ghosh and I. Saha, New J. Chem., 2011, 35, 1397 RSC .
  58. B. T. Nguyen and E. V. Anslyn, Coord. Chem. Rev., 2006, 250, 3118 CrossRef CAS PubMed  , and references cited therein.
  59. K. Ghosh and A. R. Sarkar, Org. Biomol. Chem., 2011, 9, 6551 CAS .
  60. K. Ghosh, A. R. Sarkar, A. Sommader and A.-R. Khuda-Bukhsh, Org. Lett., 2012, 14, 4314 CrossRef CAS PubMed .
  61. C. P. Mathews and K. E. vanHold, Biochemistry, The Benjamin/Cummings Publishing Comapany, Inc., Redwood City, CA, 1990 Search PubMed .
  62. M. Ronaghi, S. Karamohamed, B. Pettersson, M. Uhlen and P. Nyren, Anal. Biochem., 1996, 242, 84 CrossRef CAS PubMed .
  63. T. Tabary and L. J. Ju, J. Immunol. Methods, 1992, 156, 55 CrossRef CAS .
  64. (a) M. Doherty, C. Becher, M. Regan, A. Jones and J. Ledingham, Ann. Rheum. Dis., 1996, 166, 432 CrossRef ; (b) A. E. Hargrove, S. Nieto, T. Zhang, J. L. Sessler and E. V. Anslyn, Chem. Rev., 2011, 111, 6603 CrossRef CAS PubMed .
  65. K. Ghosh, S. S. Ali, A. R. Sarkar, A. Samadder, A. R. Khuda-Bukhsh, I. D. Petsalakis and G. Theodorakopoulos, Org. Biomol. Chem., 2013, 11, 5666 CAS .
  66. (a) K. Ghosh, A. R. Sarkar and A. P. Chattopadhyay, Eur. J. Org. Chem., 2012, 1311 CrossRef CAS ; (b) V. Haridas, S. Sahu, P. P. Praveen Kumar and A. R. Sapala, RSC Adv., 2012, 2, 12594 RSC .
  67. K.-S. Jeong and T.-Y. Park, Bull. Korean Chem. Soc., 1999, 20, 129 CAS .
  68. K. Ghosh, T. Sarkar and A. P. Chattopadhyay, Beilstein J. Org. Chem., 2010, 6, 1211 CrossRef CAS PubMed .
  69. K. Ghosh and A. Majumdar, Tetrahedron Lett., 2013, 54, 5686 CrossRef CAS PubMed .
  70. K. Ghosh and T. Sarkar, Tetrahedron Lett., 2014, 55, 1342 CrossRef CAS PubMed .
  71. J. W. Steed, Chem. Soc. Rev., 2010, 39, 3686 RSC  , and references cited therein.
  72. K. Yabuuchi, E. Marfo-Owusu and T. Kato, Org. Biomol. Chem., 2003, 1, 3464 CAS .
  73. D. K. Kumar, D. Amilan Jose, A. Das and P. Dostidar, Chem. Commun., 2005, 4059 RSC .
  74. S. Meng, Y. Tang, Y. Yin, X. Yin and J. Xie, RSC Adv., 2013, 3, 18115 RSC .
  75. P. Byrne, G. O. Lloyd, L. Applegarth, K. M. Anderson, N. Clarke and J. W. Steed, New J. Chem., 2010, 22, 2261 RSC .
  76. K. Ghosh and D. Kar, Org. Biomol. Chem., 2012, 10, 8800 CAS .
  77. K. Ghosh, D. Kar and S. Bhattacharya, Supramol. Chem., 2013 DOI:10.1080/10610278.2013.831862 .
  78. K. Ghosh, D. Kar, S. Panja and S. Bhattacharya, RSC Adv., 2014, 4, 3798 RSC .

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.